{"transactions":[{"id":1567664,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92865,"kind":"person","name":"HUEMOELLER JOHN WALTER II","position":1,"cik":"0001568485","reported_name":"HUEMOELLER JOHN WALTER II","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Convertible Note","published_at":"2024-03-19T19:59:06.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":250000,"value":62500000000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reporting Person acquired a convertible note, face value $250,000.  The note is convertible into shares of Issuer's common stock at a price of $0.02 per share."}],"balance_after":42500000,"derivative":{"exercise_price":0.02,"exercise_date":"2024-03-15","expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":12500000},"source":{"system":"sec-edgar","filing":"0001096906-24-000525","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690624000525/form4.xml","form_type":"4/A","original_submission_date":"2024-03-19"}},{"id":1567663,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92865,"kind":"person","name":"HUEMOELLER JOHN WALTER II","position":1,"cik":"0001568485","reported_name":"HUEMOELLER JOHN WALTER II","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Convertible Note","published_at":"2024-03-19T19:59:06.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":250000,"value":62500000000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting Person acquired an Amended Convertible Promissory Note in the face amount of $250,000.  The Note is convertible into shares of the Issuer's common stock at a price of $0.01 per share."}],"balance_after":30000000,"derivative":{"exercise_price":0.01,"exercise_date":"2026-01-23","expiration_date":"2033-01-24","underlying":"Common Stock","underlying_shares":25000000},"source":{"system":"sec-edgar","filing":"0001096906-24-000525","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690624000525/form4.xml","form_type":"4/A","original_submission_date":"2024-03-19"}},{"id":1567659,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92865,"kind":"person","name":"HUEMOELLER JOHN WALTER II","position":1,"cik":"0001568485","reported_name":"HUEMOELLER JOHN WALTER II","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Convertible Note","published_at":"2024-03-19T19:14:19.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":1,"price":250000,"value":250000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting Person acquired a convertible note, face value $250,000.  The note is convertible into shares of Issuer's common stock at a price of $0.02 per share."}],"balance_after":42500000,"derivative":{"exercise_price":0.02,"exercise_date":"2024-03-15","expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":12500000},"source":{"system":"sec-edgar","filing":"0001096906-24-000509","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690624000509/form4.xml","form_type":"4"}},{"id":2151777,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92865,"kind":"person","name":"HUEMOELLER JOHN WALTER II","position":1,"cik":"0001568485","reported_name":"HUEMOELLER JOHN WALTER II","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option","published_at":"2022-09-23T16:20:06.000Z","date":"2022-09-23","kind":"grant","acquired":true,"shares":5000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting Person acquired an option to purchase up to 5,000,000 shares of common stock.  50% of the shares may be purchased immediately and the remaining 50% of the shares may purchased at the date which is six (6) months following the grant date."}],"balance_after":8000000,"derivative":{"exercise_price":0.052,"expiration_date":"2032-08-22","underlying":"Common Stock","underlying_shares":5000000},"source":{"system":"sec-edgar","filing":"0001096906-22-002331","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002331/form4.xml","form_type":"4"}},{"id":2151776,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92865,"kind":"person","name":"HUEMOELLER JOHN WALTER II","position":1,"cik":"0001568485","reported_name":"HUEMOELLER JOHN WALTER II","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option","published_at":"2022-09-23T16:17:52.000Z","date":"2021-05-06","kind":"disposition_to_issuer","acquired":false,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 6, 2021, Reporting Person voluntarily agreed to cancel the option to purchase 2,000,000 shares of the Issuer's common stock granted to Reporting Person on January 2, 2019."}],"balance_after":3000000,"derivative":{"exercise_price":0.75,"exercise_date":"2019-01-02","expiration_date":"2039-01-01","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001096906-22-002330","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002330/form4.xml","form_type":"4"}},{"id":2151778,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92865,"kind":"person","name":"HUEMOELLER JOHN WALTER II","position":1,"cik":"0001568485","reported_name":"HUEMOELLER JOHN WALTER II","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option","published_at":"2022-09-23T16:16:05.000Z","date":"2020-12-10","kind":"grant","acquired":true,"shares":3000000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5000000,"derivative":{"exercise_price":0.42,"exercise_date":"2020-12-10","expiration_date":"2030-12-10","underlying":"Common Stock","underlying_shares":3000000},"source":{"system":"sec-edgar","filing":"0001096906-22-002329","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002329/form4.xml","form_type":"4"}},{"id":2151775,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92865,"kind":"person","name":"HUEMOELLER JOHN WALTER II","position":1,"cik":"0001568485","reported_name":"HUEMOELLER JOHN WALTER II","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-23T16:14:02.000Z","date":"2020-03-19","kind":"purchase","acquired":true,"shares":6000000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person acquired the shares pursuant to a share exchange with the Issuer whereby Reporting Person exchanged 100% of the Sapphire Biotech, Inc. shares common stock held by Reporting Person for 6,000,000 shares of common stock of the Issuer."}],"balance_after":6000000,"source":{"system":"sec-edgar","filing":"0001096906-22-002328","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002328/form4.xml","form_type":"4"}},{"id":2151774,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92865,"kind":"person","name":"HUEMOELLER JOHN WALTER II","position":1,"cik":"0001568485","reported_name":"HUEMOELLER JOHN WALTER II","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option","published_at":"2022-09-23T16:11:26.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 2, 2019, Reporting Person acquired an option to purchase up to 2,000,000 shares of common stock.  50% of the shares may be purchased immediately and the remaining 50% of the shares may be purchased at the date which is six (6) months following the grant date."}],"balance_after":2000000,"derivative":{"exercise_price":0.75,"expiration_date":"2039-01-01","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001096906-22-002327","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002327/form4.xml","form_type":"4"}},{"id":3947351,"issuer":{"id":161031,"kind":"organization","name":"PLEDGE PETROLEUM CORP","symbol":"PROP"},"owners":[{"id":92865,"kind":"person","name":"HUEMOELLER JOHN WALTER II","position":1,"cik":"0001568485","reported_name":"HUEMOELLER JOHN WALTER II","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-03T16:37:08.000Z","date":"2018-05-03","kind":"other","acquired":true,"shares":10000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 2, 2018, the Issuer granted shares of restricted stock to Mr. Huemoeller vesting as to 1/3rd upon the grant date, 1/3rd on the one year anniversary of the grant date and 1/3rd on the two year anniversary of the grant date."}],"balance_after":20000000,"source":{"system":"sec-edgar","filing":"0001144204-18-025112","document":"tv492976_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434110/000114420418025112/tv492976_4.xml","form_type":"4"}}]}